Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT) [Phase 2]
Phase 2 follow-on trial TRAILBLAZER-EXT evaluating donanemab (LY3002813) with video assessments in Alzheimer's disease has completed and pos…
-
EMA approval · 2025-06-13EMA Authorised: Rivastigmine Actavis (rivastigmine hydrogen tartrate) — Actavis Group PTC ehf
EMA authorised Rivastigmine Actavis (rivastigmine hydrogen tartrate) for dementia-related indications including Alzheimer's disease and Park…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease [NA]
Clinical trial status shows recruitment is ongoing for an individualized closed-loop neuromodulation therapy to treat Alzheimer's disease an…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Exercise Workshop, Skill-Based Art Approaches, and Awareness Studies for Elderly Individuals [NA]
A completed clinical trial evaluating an exercise workshop, skill-based art approaches, and awareness activities for older adults with mild …
-
FDA approval · 2025-06-10FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
FDA approved a supplemental application for Vizamyl (flutemetamol F-18) by GE Healthcare, authorizing changes to the product’s labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Eisai's investigational anti-tau agent E2814 for safety and target engagement in individuals with mild to moder…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: 18F-AV-1451 High Resolution Autopsy Study [Phase 1]
Phase 1 autopsy study update for the Alzheimer's disease imaging agent 18F-AV-1451 (flortaucipir) by Avid Radiopharmaceuticals; results have…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1
This clinical trial aims to investigate brain inflammation in Alzheimer's disease and related dementias using the PET radiotracer [11C]-CS1P…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl
A clinical trial evaluating beta-amyloid PET imaging for Alzheimer's disease using the radiotracer [18F]-Fluselenamyl is currently recruitin…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)
Clinical trial update on the F18 T807 tau PET imaging tracer (flortaucipir) used in the Dominantly Inherited Alzheimer Network, with enrollm…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease
Clinical trial update for Fluselenamyl as a beta-amyloid PET imaging agent in Alzheimer's disease. The study is currently active but not rec…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease [EARLY_Phase 1]
An early-phase clinical trial investigates glutathione's effects on brain metabolism and inflammation in Alzheimer's disease and is currentl…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: A Dyadic Approach for a Remote Physical Activity Intervention in Adults With AD and Their Caregivers [NA]
This clinical trial evaluated a remote, dyadic physical activity intervention for adults with Alzheimer's disease and their caregivers. The …
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Aβ Dynamics in LLMD [Phase 4]
A Phase 4 clinical trial evaluating beta-amyloid dynamics in late-life major depressive disorder and Alzheimer's disease is currently recrui…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Alzheimer's Disease Treated With Vagus Nerve Stimulation [NA]
Clinical trial update indicating that a study evaluating vagus nerve stimulation for Alzheimer’s disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Imaging of Brain Amyloid Plaques in the Aging Population [Phase 4]
Phase 4 clinical trial update noting ongoing enrollment (enrolling by invitation) to image brain amyloid plaques in aging populations, inclu…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Neurologic Stem Cell Treatment Study [NA]
Clinical trial update shows a neurologic stem cell treatment study sponsored by MD Stem Cells is currently recruiting. The study lists a wid…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Time Restricted Eating in Alzheimer's Disease [NA]
Ongoing clinical trial investigating time-restricted eating for mild cognitive impairment and Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients [NA]
A Phase 2 clinical trial of rhythmic light therapy for patients with mild cognitive impairment (related to Alzheimer's disease) is currently…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease [EARLY_Phase 1]
An early-stage, multi-center study is developing a novel diagnostic test for Alzheimer disease. The trial is in EARLY_PHASE1 and currently A…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Atlas of Retinal Imaging in Alzheimer's Study
The Atlas of Retinal Imaging in Alzheimer's Study sponsored by the University of Rhode Island has completed, investigating retinal imaging i…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD)
This completed clinical study assesses when amyloid PET scans are indicated and their usefulness for patients with suspected Alzheimer disea…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging
This update describes the establishment of a Chinese preclinical Alzheimer's disease study employing multiple neuroimaging techniques, with …
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
A non-interventional pilot study evaluating the role of gut flora in Alzheimer's disease has been withdrawn.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Biograph Vision 600 Versus Biograph Vision.X PET/CT [NA]
A ClinicalTrials.gov entry announces recruitment for a study comparing Biograph Vision 600 and Biograph Vision.X PET/CT imaging systems, eva…